Investor Presentaiton slide image

Investor Presentaiton

ā— Targets 2024 ā‚¬ M REVENUE 2022 pro forma EBITDA Margin Organic 386 + 8.7% Organic & inorganic + 18.1% 16% 2024 20 20 > 500 Organic > 420 mn CAGR 2021-2024 > 8.5% Organic & inorganic > 500 mn CAGR 2021-2024 > 15% > 17%
View entire presentation